Skip to main content
. 2008 May 27;28(15):4896–4914. doi: 10.1128/MCB.01775-07

TABLE 5.

Candidate metalloprotease substrates identified in conditioned medium of MMP-14-transfected MDA-MB-231 cells that show reduced shedding in the presence of the MMPIa

Candidate substrate MMPI/vehicle ratio No. of peptides
Progranulin 0.07 1
EGF-containing fibulin-like extracellular matrix protein 1 0.25 1
IGFBP-7 0.26 3
Proprotein convertase subtilisin/kexin type 9 0.28 1
Cyr61 0.29 10
Serine protease 23 0.36 1
Niemann-Pick disease, type C2 variant 0.36 4b
KIAA1392/Storkhead-box 2 0.39 1
IGFBP-4 0.40 6
Kunitz-type proteinase inhibitor 2 0.44 1
KIAA0230/peroxidasin homolog 0.45 5
Beta-2-microglobulin 0.47 1
Dickkopf-1 0.48 3
Extracellular matrix protein 1 0.50 6b
Pentraxin-related protein PTX3 0.51 1
Galectin-3-binding protein 0.51 1
Elafin 0.53 2
Thrombospondin-1 0.54 2
Cathepsin A 0.55 1
Cathepsin B 0.57 3
Legumain 0.59 3
Lupus La protein 0.59 1
Peptidyl-prolyl cis-trans isomerase B 0.64 1
Macrophage migration inhibitory factor 0.67 1
Peptidyl-prolyl cis-trans isomerase A 0.68 4b
Gamma enolase 0.68 3
DJ-1 0.69 3
Macrophage capping protein 0.70 1
Quiescin Q6 0.72 5
Stanniocalcin-1 0.75 3
a

MDA-MB-231 breast cancer cells transfected with MMP-14 were treated with the MMPI prinomastat or with DMSO vehicle under serum-free conditions for 48 h. Proteins in each conditioned medium were labeled with ICAT reagents (heavy or light), pooled, and digested with trypsin. The biotin-tagged tryptic peptides were separated by multidimensional LC and analyzed by MS-MS. Values shown are averaged abundance ratios from three separate experiments (MMPI/vehicle) for peptides detailed in Table S8 in the supplemental material. Peptides were identified at a ≥99% confidence level, unless otherwise noted in Tables S1 and S8 in the supplemental material. Abbreviations: IGFBP, insulin-like growth factor binding protein.

b

Peptide numbers include those differing only by the oxidation of a methionine, which were counted as two peptides, since they were identified independently in the MS analysis.